SI

Sachin Ingole Bhimraoji

Active Director Director DIN 07432095
DIN 07432095 First appointment Feb 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Sachin Ingole Bhimraoji

Data last updated:

Sachin Ingole Bhimraoji is a Director at Elitra Pharmaceuticals Private Limited (since 2016). The company operates in Healthcare. Elitra Pharmaceuticals Private Limited reported revenue of ₹5.4 Lakh (FY 2017).

DIN 07432095
Primary Designation Director
Industry Healthcare
First Appointment 04 Feb 2016
Oldest Company Age 12 yrs
Largest company Elitra Pharmaceuticals Private Limited · ₹5.4 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Feb 20162013₹5.4 Lakh (FY 2017)Active

Board colleagues of Sachin Ingole Bhimraoji

Directorship timeline

Open interactive timeline →
Elitra Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sachin Ingole Bhimraoji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Ingole Bhimraoji

Sachin Ingole Bhimraoji currently holds 1 directorship: Elitra Pharmaceuticals Private Limited (Director, since 04 Feb 2016, revenue ₹5.4 Lakh (FY 2017)).

Sachin Ingole Bhimraoji was first appointed on 04 Feb 2016 as Director at Elitra Pharmaceuticals Private Limited.

The current boards of Sachin Ingole Bhimraoji's companies include Kanchan Ashish Ambare (Elitra Pharmaceuticals Private Limited), Pinki Bhaskar Paunikar (Elitra Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available